Summary for Clinicians: Clinical Practice Guideline for Management of Malignant Pleural Effusions
暂无分享,去创建一个
T. Henry | M. Wahidi | D. Feller-Kopman | M. Gould | N. Maskell | N. Rahman | Y. C. Lee | D. Sterman | S. Lewis | N. Iyer | R. Diekemper | C. Reddy | M. Decamp | A. Balekian | Gary Y. C. Lee
[1] T. Henry,et al. Management of Malignant Pleural Effusions. An Official ATS/STS/STR Clinical Practice Guideline , 2018, American journal of respiratory and critical care medicine.
[2] Y. C. Lee,et al. Effect of an Indwelling Pleural Catheter vs Talc Pleurodesis on Hospitalization Days in Patients With Malignant Pleural Effusion: The AMPLE Randomized Clinical Trial , 2017, JAMA.
[3] J. Burgers,et al. A randomized controlled trial comparing indwelling pleural catheters with talc pleurodesis (NVALT-14). , 2017, Lung cancer.
[4] A. Tremblay,et al. US Hospitalizations for Malignant Pleural Effusions: Data From the 2012 National Inpatient Sample , 2017, Chest.
[5] H. Jones,et al. Interventions for the management of malignant pleural effusions: a network meta-analysis. , 2016, The Cochrane database of systematic reviews.
[6] J. M. Porcel,et al. Clinical features and survival of lung cancer patients with pleural effusions , 2015, Respirology.
[7] Elisa Anselmi,et al. Ultrasound guidance reduces pneumothorax rate and improves safety of thoracentesis in malignant pleural effusion: report on 445 consecutive patients with advanced cancer , 2014, World Journal of Surgical Oncology.
[8] S. Lanes,et al. Ultrasound guidance decreases complications and improves the cost of care among patients undergoing thoracentesis and paracentesis. , 2013, Chest.
[9] Y. C. Lee,et al. Indwelling pleural catheters reduce inpatient days over pleurodesis for malignant pleural effusion. , 2012, Chest.
[10] R. Davies,et al. Effect of an indwelling pleural catheter vs chest tube and talc pleurodesis for relieving dyspnea in patients with malignant pleural effusion: the TIME2 randomized controlled trial. , 2012, JAMA.
[11] M. Raza. Management of a malignant pleural effusion: British Thoracic Society pleural disease guideline 2010 , 2011 .
[12] Edmund Neville,et al. Management of a malignant pleural effusion: British Thoracic Society pleural disease guideline 2010 , 2010, Thorax.
[13] D. Feller-Kopman,et al. Pneumothorax following thoracentesis: a systematic review and meta-analysis. , 2010, Archives of internal medicine.
[14] G. Michaud,et al. Natural History of Asymptomatic Pleural Effusions in Lung Cancer Patients , 2007 .
[15] E. Scalzetti,et al. Phase III intergroup study of talc poudrage vs talc slurry sclerosis for malignant pleural effusion. , 2005, Chest.
[16] J. Roth,et al. Outpatient management of malignant pleural effusion by a chronic indwelling pleural catheter. , 2000, The Annals of thoracic surgery.
[17] K. Kovitz,et al. A randomized comparison of indwelling pleural catheter and doxycycline pleurodesis in the management of malignant pleural effusions , 1999, Cancer.
[18] M. Chuang,et al. Elastance of the Pleural Space: A Predictor for the Outcome of Pleurodesis in Patients with Malignant Pleural Effusion , 1997, Annals of Internal Medicine.